Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Clinical trial NCT07673900 · RECRUITING
Trial details
- NCT number
- NCT07673900
- Sponsor
- Terrestrial Bio, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2027-02-10
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.